Literature DB >> 23530170

Electronic prescribing in pediatrics: toward safer and more effective medication management.

.   

Abstract

This policy statement identifies the potential value of electronic prescribing (e-prescribing) systems in improving quality and reducing harm in pediatric health care. On the basis of limited but positive pediatric data and on the basis of federal statutes that provide incentives for the use of e-prescribing systems, the American Academy of Pediatrics recommends the adoption of e-prescribing systems with pediatric functionality. The American Academy of Pediatrics also recommends a set of functions that technology vendors should provide when e-prescribing systems are used in environments in which children receive care.

Entities:  

Mesh:

Year:  2013        PMID: 23530170     DOI: 10.1542/peds.2013-0192

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Unit of measurement used and parent medication dosing errors.

Authors:  H Shonna Yin; Benard P Dreyer; Donna C Ugboaja; Dayana C Sanchez; Ian M Paul; Hannah A Moreira; Luis Rodriguez; Alan L Mendelsohn
Journal:  Pediatrics       Date:  2014-07-14       Impact factor: 7.124

Review 2.  New technologies as a strategy to decrease medication errors: how do they affect adults and children differently?

Authors:  Margarita Ruano; Elena Villamañán; Ester Pérez; Alicia Herrero; Rodolfo Álvarez-Sala
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

Review 3.  The Safety of Drug Therapy in Children.

Authors:  Stefan Wimmer; Antje Neubert; Wolfgang Rascher
Journal:  Dtsch Arztebl Int       Date:  2015-11-13       Impact factor: 5.594

4.  Association Patterns in Open Data to Explore Ciprofloxacin Adverse Events.

Authors:  P Yildirim
Journal:  Appl Clin Inform       Date:  2015-12-16       Impact factor: 2.342

5.  Defining electronic-prescribing and infusion-related medication errors in paediatric intensive care - a Delphi study.

Authors:  Moninne M Howlett; Brian J Cleary; Cormac V Breatnach
Journal:  BMC Med Inform Decis Mak       Date:  2018-12-07       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.